Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Mouse |
Target | BDCA2 |
Identifiers | |
CAS Number | |
PubChem CID |
Litifilimab is an investigational drug being evaluated for the treatment of cutaneous lupus erythematosus and systemic lupus erythematosus. It is an anti- BDCA2 monocolonal antibody. [1] [2] [3]
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Mouse |
Target | BDCA2 |
Identifiers | |
CAS Number | |
PubChem CID |
Litifilimab is an investigational drug being evaluated for the treatment of cutaneous lupus erythematosus and systemic lupus erythematosus. It is an anti- BDCA2 monocolonal antibody. [1] [2] [3]